Both in Surgical Instruments
Boston Scientific vs Solventum
Over the past year BSX returned −57.2% and SOLV returned +13.6%; their daily moves had a correlation of 0.20.
BSX −57.2% SOLV +13.6%Growth of $1, one year, split-adjusted
| Metric | BSX | SOLV |
|---|---|---|
| Price | $43.86 | $81.75 |
| Market cap | $63.56B | $13.92B |
| Today | −2.66% | −1.48% |
| 1 month | 0.0% | −8.5% |
| 6 months | −23.3% | +23.0% |
| Year to date | −54.0% | +3.2% |
| 1 year | −57.2% | +13.6% |
| Revenue growth (YoY) | +7.5% | +2.2% |
| Gross margin | 70.7% | 58.2% |
| Net margin | 16.7% | 4.2% |
| P/E (TTM) | 17.3× | 9.7× |
| Price / sales | 3.0× | 1.7× |
| Net cash | -$12.09B | -$4.88B |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 23.2% |
| Short % of float | 2.8% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).